U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA History
  4. FDA Leadership: 1907 to Today
  5. Arthur Hayes
  1. FDA Leadership: 1907 to Today

Arthur Hull Hayes

Photo of Arthur Hull Hayes Jr., M.D.

Arthur Hull Hayes Jr., M.D.

4/13/1981 - 9/11/1983*

Arthur Hull Hayes, Jr., was born in Highland Park, Michigan, in 1933. A Rhodes Scholar, he received an M. D. from Cornell in 1964. Following his internship, residency, and a two-year stint in the army, Hayes began his career in clinical pharmacology at his medical alma mater from 1968 to 1972. He then moved to the faculty of Pennsylvania State College of Medicine.

In April 1981 Richard Schweiker, Secretary of Health and Human Services, appointed Hayes to lead FDA. Under Hayes, FDA dealt with the Tylenol crisis, ushered in the first orphan drugs, and carried out major reorganizations of drugs, biologics, and other areas, among other activities.

Hayes left FDA in September 1983 to become dean and provost of New York Medical College, and in 1986 he shifted to executive positions in the pharmaceutical industry. Among other recognitions, Hayes served on the editorial boards of Clinical Pharmacology and Therapeutics, Rational Drug Therapy, and the Journal of Clinical Pharmacology, he served as president of both the American Society of Clinical Pharmacology and Therapeutics and the United States Pharmacopoeial Convention, and he received honorary degrees from St. John's University and New York Medical College.

 

*Mark Novitch, M.D., deputy commissioner from 1979 to 1985, acted as commissioner on two separate occasions, totaling approximately 13-1/2 months, between the tenures of Jere Goyan, Arthur Hayes, and Frank Young.

Back to Top